Citadel Advisors’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,042
| Closed | -$26.1K | – | 6312 |
|
|
2022
Q4 | $26.1K | Buy |
1,042
+626
| +150% | +$15.7K | ﹤0.01% | 5487 |
|
|
2022
Q3 | $13K | Buy |
+416
| New | +$13K | ﹤0.01% | 5608 |
|
|
2022
Q1 | – | Sell |
-2,361
| Closed | -$119K | – | 6832 |
|
|
2021
Q4 | $119K | Sell |
2,361
-1,336
| -36% | -$67.3K | ﹤0.01% | 5805 |
|
|
2021
Q3 | $241K | Buy |
+3,697
| New | +$241K | ﹤0.01% | 5224 |
|
|
2021
Q2 | – | Sell |
-6,294
| Closed | -$330K | – | 6822 |
|
|
2021
Q1 | $330K | Buy |
6,294
+4,155
| +194% | +$218K | ﹤0.01% | 4939 |
|
|
2020
Q4 | $145K | Buy |
2,139
+670
| +46% | +$45.4K | ﹤0.01% | 4592 |
|
|
2020
Q3 | $56K | Sell |
1,469
-868
| -37% | -$33.1K | ﹤0.01% | 4371 |
|
|
2020
Q2 | $90K | Buy |
+2,337
| New | +$90K | ﹤0.01% | 4264 |
|
|
2020
Q1 | – | Sell |
-556
| Closed | -$63K | – | 5134 |
|
|
2019
Q4 | $63K | Buy |
+556
| New | +$63K | ﹤0.01% | 4354 |
|
|
2019
Q1 | – | Sell |
-2,072
| Closed | -$61K | – | 4856 |
|
|
2018
Q4 | $61K | Buy |
+2,072
| New | +$61K | ﹤0.01% | 4084 |
|
|
2018
Q3 | – | Sell |
-225
| Closed | -$5K | – | 4573 |
|
|
2018
Q2 | $5K | Sell |
225
-267
| -54% | -$5.93K | ﹤0.01% | 4115 |
|
|
2018
Q1 | $19K | Sell |
492
-403
| -45% | -$15.6K | ﹤0.01% | 3878 |
|
|
2017
Q4 | $52K | Buy |
+895
| New | +$52K | ﹤0.01% | 3619 |
|
|
2017
Q3 | – | Sell |
-722
| Closed | -$61K | – | 3945 |
|
|
2017
Q2 | $61K | Buy |
+722
| New | +$61K | ﹤0.01% | 3370 |
|